This Protocol is listed in the following Categories:
Biochemistry and protein analysis, Isolation, purification and separation

Author(s): Markus Hafner, Anton Schmitz and Michael Famulok
Lab/Group: Famulok Lab
DOI: 10.1038/nprot.2006.414

Extraction of the SecinH3 from mouse liver

Markus Hafner, markus.hafner@uni-bonn.de, LIMES Program Unit Chemical Biology & Medicinal Chemistry, c/o Kekulé Institut für Organische Chemie und Biochemie, University of Bonn

Anton Schmitz, anton.schmitz@uni-bonn.de, LIMES Program Unit Chemical Biology & Medicinal Chemistry, c/o Kekulé Institut für Organische Chemie und Biochemie, University of Bonn

Michael Famulok, m.famulok@uni-bonn.de, LIMES Program Unit Chemical Biology & Medicinal Chemistry, c/o Kekulé Institut für Organische Chemie und Biochemie, University of Bonn

Lab/Group: Famulok Lab

Journal: Nature

Article Title: Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance

Introduction

Mice fed with the cytohesin inhibitor SecinH3 for two days develop hepatic insulin resistance that can be identified by reduced liver glycogen levels, increased serum insulin and ketone body levels and decreased serum non-esterified fatty acid. To confirm the presence and identity of SecinH3 in mouse liver, we extracted the compound from liver homogenates with chloroform and identified it by LC/MS.

Materials

Reagents

ca. 300 mg mouse liver
Chloroform
Methanol
PBS

Equipment

HPLC/MS: Agilent 1100 Series HPLC with Bruker Daltonics Esquire Series MS

HPLC columns:
1. 10×4.0 mm with Nucleosil RP18 5 µm
2. 125×2.0 mm with MultoHigh RP18 5 µm

Polytron (Kinematica)

SpeedVac

Time Taken

Procedure

1. 300 mg mouse liver each weighed into 15 mL centrifugation tubes and taken up in 1 ml PBS, 2 mL chloroform added
2. mouse liver homogenized by polytron
3. incubated at RT for 30’ under agitation,
4. Centrifuged 5’ at maximum speed
5. Chloroform phase transferred into fresh centrifugation tube
6. Water phase extracted second time on shaker with 1.5 mL chloroform, 20’
7. Centrifuged 5’ at maximum speed
8. Chloroform phases combined and solvent removed on SpeedVac
9. Residue dissolved in 100 µL/(100 mg liver) methanol, centrifuged 5’ at 14.000 rpm and liquid transferred into HPLC glass vial
10. Fractionated via HPLC on Nucleosil RP18 material 5 µm (10×4.0 mm column); gradient:
0-7 min: 70% water, 30% methanol
7-15 min: 40% water, 60% methanol
15-20 min: 100% methanol;
fractions 9-12 min collected
11. solvent of collected fractions removed by SpeedVac and residue taken up in 50 µl methanol
12. fractionated by HPLC, column: MultoHigh RP18 5 µM (125×2.0 mm column); gradient:
0 min: 50% water, 50% methanol
5 min: 50% water, 50% methanol
25 min: 10% water, 90% methanol
25.1 min: 100% methanol
13. SecinH3 elutes at ca. 20 min; analyzed by MS

Troubleshooting

Critical Steps

Anticipated Results

References

Acknowledgements

We thank Klaus Rotscheidt for help in establishing this protocol.

Keywords

SecinH3,
mouse liver
high performance liquid chromatography (HPLC)
Mass spectrometry

Post a comment


Extra navigation

Search Protocols

Feedback

0 comments have been posted on this protocol

ADVERTISEMENT